-
公开(公告)号:KR101230932B1
公开(公告)日:2013-02-07
申请号:KR1020060123557
申请日:2006-12-07
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 플라본을 담지시킨 고분자 구형복합체를 함유하는 화장료 조성물에 관한 것으로, 보다 구체적으로는 피부내 염증을 억제하는 작용은 뛰어나지만 화장료 제형에서의 용해도가 낮아 결정으로 석출되는 플라본들을 고분자 구형복합체에 담지시킴으로써 플라본들의 생리활성 효과가 제공될 수 있는 화장료 조성물을 제공하는 것이다.
아피게닌(apigenin), 루테올린(luteolin), 디오스메틴(diosmetin), PDE4, 다공성 고분자 입자, 구형 복합체-
公开(公告)号:KR101199113B1
公开(公告)日:2012-11-09
申请号:KR1020090107573
申请日:2009-11-09
Applicant: (주)아모레퍼시픽
CPC classification number: A23F3/405
Abstract: 본 발명은 목재를 이용하여 착향차를 제조하는 방법 및 그에 의해 제조된 착향차에 관한 것으로, 보다 상세하게는 적절한 착향 시간 및 온도로 설정된 착향 방법을 통해 천연 목재를 이용한 기호성과 향미가 우수한 착향차의 제조방법 및 그에 의해 제조된 착향차에 관한 것이다.
착향차, 목재, 숙성, 편백나무, 백향목, 향나무, 삼나무, 오동나무, 참나무-
公开(公告)号:KR1020120015082A
公开(公告)日:2012-02-21
申请号:KR1020100077324
申请日:2010-08-11
Applicant: (주)아모레퍼시픽
CPC classification number: A23L2/38 , A23L2/52 , A23L2/60 , A23L3/16 , A23L23/10 , A23L33/10 , A23L33/16 , A23V2250/032 , A23V2250/282 , A23V2250/511
Abstract: PURPOSE: A liquid food composition without unpleasant taste removed is provided to add ionic materials into chitoic acid and chito-oligosaccharide for removing astringent taste. CONSTITUTION: A liquid food composition without unpleasant taste contains 0.1-30wt% of chitoic acid or chito-oligosaccharide, and 25-50wt% of compound mixture. The compound mixture contains sodium lactate, potassium lactate, sodium stannate, potassium sodium tartrate, disodium succinate, sodium malic acid, sodium citrate, potassium citrate, and trisodium citrate.
Abstract translation: 目的:提供没有令人不愉快的味道去除的液体食物组合物,以将离子材料加入到chitoic acid和chito-oligosaccharide中以除去涩味。 构成:没有不愉快味道的液体食物组合物含有0.1-30wt%的chitoic acid或chito-oligosaccharide,以及25-50wt%的复合混合物。 复合混合物含有乳酸钠,乳酸钾,酒石酸钠,酒石酸钠钠,琥珀酸二钠,苹果酸钠,柠檬酸钠,柠檬酸钾和柠檬酸三钠。
-
公开(公告)号:KR1020110110054A
公开(公告)日:2011-10-06
申请号:KR1020110029587
申请日:2011-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/484 , A61K36/48 , A61P25/28 , A61P25/00
CPC classification number: A61K31/35 , A61K31/366 , A61K36/48
Abstract: 본 발명은 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 유효 성분으로 포함하여 지방 세포의 분화를 억제하며, 신체 면역을 증진시키고, 독성 물질을 해독하며, 퇴행성 신경 장애를 예방 또는 개선하는 조성물을 개시한다.
Abstract translation: 本发明涉及一种组合物,其包含作为活性成分的香草雌酚或含有香豆素的豆提取物,其中脂肪细胞分化被抑制,身体的免疫系统得到改善,有毒物质被清除,并且可以预防或改善神经变性疾病。
-
65.
公开(公告)号:KR1020110080470A
公开(公告)日:2011-07-13
申请号:KR1020100000718
申请日:2010-01-06
Applicant: (주)아모레퍼시픽
CPC classification number: A23L33/30 , A23L19/00 , A23L33/105 , A23L33/127 , A23V2200/324 , A23V2250/2124
Abstract: PURPOSE: A health food composition for enhancing the immunity containing a red ginseng extract and a medical herb extract is provided to offer the excellent antioxidant property. CONSTITUTION: A health food composition for enhancing the immunity contains 5~70wt% of medical herb extract fermented for 3~6years. The health food composition contains an extra-high pressure-processed red ginseng extract. Medical herbs to produce the medical herb extract are saccharide-processed before a fermenting process.
Abstract translation: 目的:提供含有红参提取物和药草提取物的增强免疫力的保健食品组合物,提供优异的抗氧化性能。 构成:用于提高免疫力的保健食品组合物含有5〜70重量%的药用植物提取物,发酵3〜6年。 保健食品组合物含有超高压加工红参提取物。 生产药草提取物的药草在发酵过程之前进行糖加工。
-
公开(公告)号:KR1020110060140A
公开(公告)日:2011-06-08
申请号:KR1020090116640
申请日:2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/481 , A61P21/00 , A61P29/00 , A23L1/30
CPC classification number: A61K36/481 , A23L33/105 , A23V2002/00 , A23V2250/21
Abstract: PURPOSE: A composition containing Astragali Radix extract is provided to promote the expression of PGC1-alpha(peroxisome proliferator-activated receptor gamma coactivator 1-alpha). CONSTITUTION: A composition for promoting body energy consumption and muscle metabolism and strengthen muscle contains 1-80 weight% of Astragali Radix extract as an active ingredient. The composition is a pharmaceutical composition or food composition. The Astragali Radix extract is isolated using leaves, stems, and roots of Astragali Radix. The Astragali Radix extract is prepared by extracting Astragali Radix in 10 time volume of distilled water for three hours, filtering with a Whatman No.1 filter, and freeze-drying at -70°C.
Abstract translation: 目的:提供含有黄芪提取物的组合物,以促进PGC1-α(过氧化物酶体增殖物激活受体γ共激活因子1-α)的表达。 构成:用于促进身体能量消耗和肌肉代谢并增强肌肉的组合物含有1-80重量%的黄芪提取物作为活性成分。 组合物是药物组合物或食物组合物。 黄芪提取物使用黄芪的叶,茎和根进行分离。 黄芪提取物通过在10倍体积的蒸馏水中提取黄芪提取物三小时,用Whatman 1号滤器过滤,并在-70℃下冷冻干燥制备。
-
公开(公告)号:KR1020110028741A
公开(公告)日:2011-03-22
申请号:KR1020090086317
申请日:2009-09-14
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for improving exercise endurance capacity and recovery capability is provided to form a health food with the composition containing chito-oligosaccharide. CONSTITUTION: A composition for improving exercise endurance capacity and recovery capability contains chito-oligosaccharide as an active component. The chito-oligosaccharide increases the utilization coefficient of internal fat acid of a user and reduces the concentration of lactic acid in blood. The chito-oligosaccharide additionally increases the storage content of glycogen of the user.
Abstract translation: 目的:提供一种用于提高运动耐力和恢复能力的组合物,以形成含有低聚半乳糖的组合物的保健食品。 构成:用于提高运动耐力和恢复能力的组合物含有作为活性成分的低聚半乳糖。 氯低聚糖增加了使用者的内部脂肪酸的利用系数,降低了血液中乳酸的浓度。 氯低聚糖另外增加了使用者糖原的储存量。
-
公开(公告)号:KR1020100134381A
公开(公告)日:2010-12-23
申请号:KR1020090052982
申请日:2009-06-15
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for promoting the alcoholysis inside a human body is provided to use a post-heating fermented tea extract as an active ingredient for reducing hangover. CONSTITUTION: A composition for promoting the alcoholysis contains a post-heating fermented tea extract using non-pathogenic microorganisms as an active ingredient. The non-pathogenic microorganisms are selected from the group consisting of yeast, lactobacillus, saccharomyces genus, bacillus genus, and aspergillus genus. The composition promotes the activity of alcohol dehydrogenase and acetaldehyde dehydrogenase.
Abstract translation: 目的:提供一种用于促进人体内醇解的组合物,使用后加热发酵茶提取物作为减少宿醉的活性成分。 构成:用于促进醇解的组合物包含使用非致病微生物作为活性成分的后加热发酵茶提取物。 非病原微生物选自酵母,乳杆菌属,酵母属,芽孢杆菌属和曲霉属。 该组合物促进醇脱氢酶和乙醛脱氢酶的活性。
-
公开(公告)号:KR1020100127728A
公开(公告)日:2010-12-06
申请号:KR1020100049181
申请日:2010-05-26
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/48 , A23L2/52 , A23L33/105 , A61K2236/333 , A23V2200/30
Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.
Abstract translation: 目的:提供含有用低分子量分离的大豆提取物的组合物,以改善血液循环和治疗肥胖症,糖尿病和高脂血症。 构成:用于改善血液循环的组合物含有用1-7%的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇,乙醇,异丙醇,正丙醇,正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。
-
公开(公告)号:KR1020100127420A
公开(公告)日:2010-12-06
申请号:KR1020090045858
申请日:2009-05-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/79 , A61K36/896 , A61K36/258
CPC classification number: A61K36/79 , A61K36/258 , A61K36/896 , A61K2300/00
Abstract: PURPOSE: A ginseng complex composition which enhances the bioavailability of saponin is provided to improve the physiological activity of ginseng saponin. CONSTITUTION: A ginseng complex composition for enhancing the bioavailability of saponiin contains Schisandra chinensis extract or Liriope platyphylla extract and ginseng extract containing saponin. The ginseng extract is ginseng fruit extract. The saponin is ginsenoside Re. A composition for enhancing the bioavailability of saponin contains Schisandra chinensis extract or Liriope platyphylla extract as an active ingredient.
Abstract translation: 目的:提高人参皂苷生理活性,提高皂角苷的生物利用度。 构成:提高saponiin生物利用度的人参复合物组合物含有五味子提取物或Liriope platyphylla提取物和含有皂苷的人参提取物。 人参提取物是人参水果提取物。 皂苷是人参皂甙Re。 用于提高皂角苷生物利用度的组合物含有五味子提取物或Liriope platyphylla提取物作为活性成分。
-
-
-
-
-
-
-
-
-